| Pack Size/Qty | Price | Unit Price | |
| 90 Tablet/s | $80.50 | $0.90 | |
| 60 Tablet/s | $59.40 | $0.99 | |
| 30 Tablet/s | $45.00 | $1.49 |
Generic Name : Hydroxychloroquine Sulfate
Brand Name : Plaquenil
Manufacturer Name : IPCA ,India
Product Code : CRX 50
Delivery Days : 10 to 15 working days
Composition : Hydroxychloroquine Sulfate
Packaging : Tablet/s (Blister Packing)
Hydroxychloroquine sulfate, often abbreviated as HCQS, is a medication that has gained significant attention in recent years due to its potential use in the treatment and prevention of various medical conditions, most notably malaria and certain autoimmune diseases. This 700-word article aims to provide a comprehensive overview of HCQS 200 mg, including its uses, mechanisms of action, potential side effects, and important considerations.
HCQS, which contains hydroxychloroquine as its active ingredient, is a medication that belongs to the class of drugs known as antimalarials. Initially developed to treat and prevent malaria, it has found use in the management of several autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and discoid or systemic lupus erythematosus. HCQS is typically administered in tablet form, with each tablet containing 200 mg of hydroxychloroquine.
The precise mechanism of action of HCQS is not fully understood. However, it is thought to work by several mechanisms, including:
Antimalarial Properties: HCQS interferes with the replication of the malaria parasite within the red blood cells, preventing the progression of the disease.
Immunomodulatory Effects: In autoimmune diseases, HCQS may modify the activity of the immune system by reducing inflammation and suppressing immune responses that contribute to the pathology of the condition.
Inhibiting Cytokine Production: HCQS can inhibit the production of various pro-inflammatory cytokines, which play a crucial role in autoimmune diseases.
HCQS is prescribed for various medical conditions, including:
Malaria: HCQS is used to treat and prevent different types of malaria. It is often used in combination with other antimalarial drugs for this purpose.
Rheumatoid Arthritis: HCQS is employed in the management of rheumatoid arthritis, where it helps to reduce joint pain and inflammation.
Lupus: Systemic lupus erythematosus (SLE) and discoid lupus erythematosus (DLE) are autoimmune diseases in which HCQS may be used to manage symptoms and prevent disease flares.
The typical dose of HCQS 200 mg tablets may vary depending on the condition being treated. Patients should always follow their healthcare provider's instructions for dosing. For malaria prevention, the dosing regimen might involve taking one tablet once a week. In the treatment of autoimmune diseases, higher doses may be recommended.
Gastrointestinal Disturbances:
Skin Reactions
Visual Changes
Blood Disorders
Cardiac Effects
HCQS is contraindicated in individuals with known hypersensitivity to hydroxychloroquine or any of its ingredients. Additionally, special precautions and close monitoring are advised in certain situations, such as:
Patients with Heart Conditions: HCQS should be used cautiously in those with pre-existing heart conditions, as it can affect the heart's electrical conduction.
Patients with Eye Conditions: Individuals with pre-existing eye problems should undergo regular eye examinations while taking HCQS.
Pregnancy and Breastfeeding: HCQS may be used during pregnancy or breastfeeding, but the risks and benefits should be carefully weighed, and close monitoring is essential.
HCQS can interact with other medications, potentially increasing or decreasing their effects. Common drug interactions include:
Antacids: Antacids containing aluminum or magnesium can reduce the absorption of HCQS. These should be taken at least 4 hours apart.
Digoxin: HCQS can increase digoxin levels, potentially leading to toxicity.
Methotrexate: When used in combination with methotrexate, HCQS may increase the risk of myelosuppression.
Cyclosporine: Combining HCQS with cyclosporine may lead to an increased risk of retinopathy.
Patients should inform their healthcare provider about all medications they are taking to minimize the risk of interactions
HCQS 200 mg is a medication with a long history of use in treating and preventing malaria and managing various autoimmune diseases. While it can be highly effective, it is essential to use HCQS under the guidance of a healthcare provider who can monitor its effects and manage any potential side effects or interactions. When used responsibly, HCQS can be a valuable tool in improving the health and well-being of those affected by the conditions it is designed to treat. Patients should always consult their healthcare provider for personalized guidance on HCQS use.